Form D · Biotechnology
Osteonovus, Inc.
Toledo, OH · CIK 0001595323
Offering snapshot reported Sep 9, 2020 · SEC filing
- Reported sold
- $1.08M Offering amount: $3M
- Investors reported
- 11 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Oct 4, 2018 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$775,000 → $1,075,000
- Reported investors9 → 11
- Minimum accepted$50,000 → $25,000
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 9, 2020 | Amendment | $1,075,000 | $300,000vs Sep 23, 2019 | 11 | SEC filing |
| Sep 23, 2019 | Amendment | $775,000 | $275,000vs Dec 13, 2018 | 9 | SEC filing |
| Dec 13, 2018 | Amendment | $500,000 | $450,000vs Oct 10, 2018 | 6 | SEC filing |
| Oct 10, 2018 | Initial | $50,000 | No comparison | 1 | SEC filing |
| Apr 24, 2017 | Amendment | $2,500,000 | $1,250,000vs Feb 18, 2016 | 12 | SEC filing |
| Feb 18, 2016 | Amendment | $1,250,000 | $1,200,000vs Dec 26, 2013 | 8 | SEC filing |
| Aug 5, 2014 | Amendment | $200,000 | $150,000vs Dec 26, 2013 | 4 | SEC filing |
| Dec 26, 2013 | Initial | $50,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity, Debt, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-323166
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| None | None |
Source: Form D, filed Sep 9, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Anand K Agarwal | Director, Executive |
| Sarit B Bhaduri | Director, Executive |
| Michael J Callahan | Director, Executive |
| Vijay K Goel | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1510 North Westwood Suite 204
Toledo, OH, 43606
Toledo, OH, 43606